SCHEMBL6322716

SCHEMBL6322716

CC(C(=O)O)c1nc2c(=O)n(C)c(=O)n(C)c2nc1NNc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 5/20 0.46
GAA P10253 4/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
USP2 O75604 1/20 0.44
RECQL P46063 1/20 0.44
GLA P06280 1/20 0.43
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PKM P14618 2/20 0.40
LMNA P02545 3/20 0.40
HTT P42858 1/20 0.40
GFER P55789 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6314078 0.76 KDM4E (0.36) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL6317229 0.76 HTT (0.43) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL6315748 0.76 MAPT (0.40) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL6315606 0.74 ALDH1A1 (0.56) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL6317109 0.71 ALDH1A1 (0.41) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL6314318 0.69 ALDH1A1 (0.43) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL5447095 0.68 KDM4E (0.60) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL3668402 0.65 KDM4E (1.00) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL7526429 0.64 KDM4E (0.78) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL28476188 0.64 KDM4E (0.44) KDM4EALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 KDM4E 1278/4885ALDH1A1 1744/4885GAA 3226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.